Tiger BufordYour Orthopedic Industry Expert (free today)

GLP-1s - delaying versus increasing orthopedic procedures

15 May 2026 · 1 min

Watch on YouTube

0:46

In a brief interview segment, Tiger Buford raises a question about the widespread use of GLP‑1 receptor agonists, now taken by an estimated 15‑20% of Americans. He posits two opposing effects on orthopedics: (1) significant weight loss may postpone or eliminate the need for elective procedures such as lumbar spine fusions, and (2) the resulting increase in physical activity could raise the incidence of sports‑related injuries, exemplified by meniscus tears from activities like pickleball. Buford invites panelists to share their predictions on the net impact of GLP‑1 therapy on orthopedic surgery rates.

Chapters

So there's a debate going on around the GLPs. They're, you know, I don't know, 15, 20% of Americans are on GLP-1s now. It's a miracle drug. They're finding more benefits every, every month. Is that going to decrease the amount of elective procedures or is it going— and in my theory is, you know, you lose weight, you're, you don't need a back fusion as soon, or maybe Maybe you delay it forever. And then on the other side is an increasing sports medicine injuries. Cuz when you, when you go from 230 pounds to 180, all of a sudden you're playing pickleball and you tear your meniscus. So I'd love to hear, I'd love to hear your, your, your big guess on the, the effect of GLP-1. Good question.